Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

ALGS FY 2018 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALGSAligos Therapeutics, Inc.

$45M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.66

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$9M

Stock-Based Comp.

$179,000

Balance Sheet

Total Assets

$108M

Total Liabilities

$121M

Stockholders' Equity

-$14M

Cash & Equivalents

$24M

← Q1 2018 All Quarters